Related Experiment Video

Updated: Aug 19, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

STAT3 regulates Nemo-like kinase by mediating its interaction with IL-6-stimulated TGFbeta-activated kinase 1 for

Hirotada Kojima1, Takanori Sasaki, Tohru Ishitani

  • 1Department of Immunology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.

Proceedings of the National Academy of Sciences of the United States of America
|March 15, 2005
PubMed

Insights

Signal transducer and activator of transcription 3 (STAT3) enhances its own Ser-727 phosphorylation by scaffolding TAK1-NLK kinases in the IL-6 YXXQ pathway. This mechanism boosts STAT3 transcriptional activity.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Signal transduction

Background:

  • Signal transducer and activator of transcription 3 (STAT3) requires both tyrosine and Ser-727 phosphorylation for transcriptional activity.
  • Interleukin-6 (IL-6) signaling activates STAT3 through distinct pathways originating from gp130 motifs.
  • The role of STAT3 in regulating specific phosphorylation events within these pathways remains incompletely understood.

Purpose of the Study:

  • To investigate the interaction between TGF-beta-activated kinase 1 (TAK1), Nemo-like kinase (NLK), and STAT3.
  • To elucidate the mechanism by which STAT3 Ser-727 phosphorylation is regulated, particularly via the IL-6 YXXQ motif pathway.
  • To determine the scaffolding role of STAT3 in kinase activation.

Main Methods:

  • Co-immunoprecipitation to assess protein interactions.
  • Cellular depletion studies (e.g., STAT3 knockdown) to evaluate pathway dependencies.
  • Expression of STAT3 carboxyl-terminal regions in knockdown cells to map functional domains.
  • Analysis of STAT3 and NLK activation in response to IL-6 and TGF-beta stimulation.

Main Results:

  • TAK1 interacts with STAT3, and the TAK1-NLK pathway is activated by IL-6 via the YXXQ motif, leading to STAT3 Ser-727 phosphorylation.
  • STAT3 depletion significantly reduced IL-6-induced NLK activation, indicating STAT3's crucial role.
  • STAT3 functions as an in vivo scaffold for TAK1 and NLK through its carboxyl terminus, enhancing IL-6-induced NLK activation.
  • TGF-beta did not induce STAT3 Ser-727 phosphorylation, and STAT3 expression did not enhance TGF-beta-induced NLK activation.

Conclusions:

  • STAT3 acts as a scaffold protein, specifically enhancing the efficiency of its own Ser-727 phosphorylation within the IL-6 YXXQ motif-derived pathway.
  • This scaffolding function of STAT3 is critical for optimal activation of the TAK1-NLK pathway in response to IL-6.
  • The findings reveal a novel feedback mechanism where STAT3 actively promotes its own activation through specific kinase interactions.

More Related Videos

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...